Stilla Technologies announced it has entered into agreements with 12 distributors throughout EMEA: LABGENE Scientific (Switzerland), CARLO ERBA Reagents (Italy), Bonsai Lab (Portugal and Spain), SEM (Turkey), Explorea (Czech Republic, Slovakia, Hungary), Biodynamics (Greece), AH diagnostics (Sweden, Norway, Finland, Denmark, Baltic countries), Alliance Global (Gulf, Levant, African Continent including South Africa, Central Asia, Pakistan), Danyel Biotech (Israel), Zahrawi Group (Bahrain), TK Biotech (Poland), and RIDACOM (Bulgaria). The agreements grant distribution rights to Stilla's full product portfolio including the six-color naica® system Stilla's next generation multiplexing digital PCR platform as well as microfluidic chips and reagents optimized for a wide variety of applications including cancer and liquid biopsy studies, cell and gene therapies, and infectious disease detection.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.69 PHP | +0.83% | +2.00% | -14.10% |
Apr. 17 | Alliance Global's Profit Jumps 20% in 2023 on Higher Revenue | MT |
Apr. 16 | Transcript : Alliance Global Group, Inc., 2023 Earnings Call, Apr 16, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.10% | 1.5B | |
+13.05% | 883B | |
0.00% | 239B | |
+24.73% | 178B | |
-7.11% | 128B | |
+34.81% | 79.12B | |
-3.89% | 74.88B | |
-15.83% | 51.46B | |
-22.98% | 38.61B | |
+24.46% | 32.72B |
- Stock Market
- Equities
- AGI Stock
- News Alliance Global Group, Inc.
- Stilla Technologies Expands EMEA Footprint with New Distribution Partnerships